SDS Biotech K.K. reported consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported net sales of ¥4,229 million against ¥3,673 million a year ago. Operating income was ¥531 million against ¥405 million a year ago. Ordinary income was ¥458 million against ¥338 million a year ago. Net income was ¥320 million or ¥40.92 per diluted share against ¥210 million or ¥26.83 per diluted share a year ago. Net income before taxes was ¥338,826,000 against ¥460,360,000 a year ago.

The company provided consolidated earnings guidance for the fiscal year ending March 2016. For the year, the company expects to report net sales of ¥20,880 million, operating income of ¥2,170 million, ordinary income of ¥1,800 million and net income of ¥1,100 million or ¥140.46 per share.